Banbit, main stream media exposure is a minimal factor here and is not something RLF, etc., should be pursuing. You and the rest of us can try to help with that, among others. The FDA knows all about RLF and my guess is RLF and the FDA know they are in difficult territory given that RLF is a tiny company and if the FDA gives them the go ahead that puts them right in Pfizer and Big Pharma territory. There is great pressure there and the FDA may understandably want to be very sure they are doing the right thing since they know the forces that could be launched against any bad judgments they make.
If you were in charge of RLF PR you would be annoying the hell out of the FDA probably resulting in greater delays because of that even if they were happy with the data (even though they should be above such responses). Also, not that many more doctors world wide would know about RLF and that doesn't matter so much because the FDA does know about it.
Further, RLF shouldn't be open to the general public about everything. They are walking a delicate walk on the edge of Big Pharma status. They should focus above all on being open and honest with the FDA. I think they are doing that. They know they have the right stuff and handling it correctly in working closely with the FDA will produce enormous benefits to mankind and to share holders.
They also know that a PR campaign like the one you want could trash or slow down their success. I also am going to suggest that RLF and the FDA are not all that impressed with ALL CAPS PRs which you seem to think would seize the day. Of course, I could be wrong and maybe RLF should also break new ground by moving to ALL CAPS press releases in the future. No doubt, that would force Pfizer, Moderna, AstraZeneca, etc., etc. to follow in kind and via this great PR victory everyone would be made aware that RLF was the real leader in dealing with COVID19.
